AMELOBLASTOMA

AMELOBLASTOMA was reported 53 times

AMELOBLASTOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
1 Topoisomerase Inhibitor [EPC] 15 0.0002
2 Parenteral Iron Replacement [EPC] 1 0.0001
3 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
4 Platinum-based Drug [EPC] 16 0.0001
5 Alkylating Drug [EPC] 12 0.0000
6 Recombinant Human Growth Hormone [EPC] 1 0.0000
7 Complement Inhibitor [EPC] 2 0.0000
8 Proteasome Inhibitor [EPC] 2 0.0000
9 Tetracycline-class Drug [EPC] 1 0.0000
10 Catecholamine [EPC] 1 0.0000
11 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
12 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
13 RANK Ligand Inhibitor [EPC] 2 0.0000
14 Interleukin-12 Antagonist [EPC] 1 0.0000
15 Interleukin-23 Antagonist [EPC] 1 0.0000
16 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
17 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
18 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
19 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
20 Opioid Agonist [EPC] 2 0.0000
21 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
22 Leukocyte Growth Factor [EPC] 1 0.0000
23 Janus Kinase Inhibitor [EPC] 1 0.0000
24 Microtubule Inhibitor [EPC] 1 0.0000
25 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
26 Anti-epileptic Agent [EPC] 1 0.0000
27 GLP-1 Receptor Agonist [EPC] 2 0.0000
28 Osmotic Laxative [EPC] 1 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
30 Corticosteroid [EPC] 4 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000